1. Home
  2. THO vs RCUS Comparison

THO vs RCUS Comparison

Compare THO & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Thor Industries Inc.

THO

Thor Industries Inc.

HOLD

Current Price

$71.25

Market Cap

3.8B

Sector

Industrials

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$24.23

Market Cap

3.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
THO
RCUS
Founded
1980
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Homebuilding
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.8B
3.8B
IPO Year
1994
2018

Fundamental Metrics

Financial Performance
Metric
THO
RCUS
Price
$71.25
$24.23
Analyst Decision
Buy
Buy
Analyst Count
11
10
Target Price
$111.75
$31.90
AVG Volume (30 Days)
491.4K
1.4M
Earning Date
06-03-2026
05-05-2026
Dividend Yield
2.67%
N/A
EPS Growth
N/A
N/A
EPS
2.59
N/A
Revenue
$9,579,490,000.00
$247,000,000.00
Revenue This Year
$1.21
N/A
Revenue Next Year
$5.17
$45.62
P/E Ratio
$28.13
N/A
Revenue Growth
N/A
N/A
52 Week Low
$69.71
$11.58
52 Week High
$122.83
$31.74

Technical Indicators

Market Signals
Indicator
THO
RCUS
Relative Strength Index (RSI) 42.46 25.83
Support Level $70.07 $23.91
Resistance Level $80.73 $24.33
Average True Range (ATR) 2.34 1.31
MACD -0.50 -0.71
Stochastic Oscillator 27.25 0.66

Price Performance

Historical Comparison
THO
RCUS

About THO Thor Industries Inc.

Based in Elkhart, Indiana, Thor Industries manufactures Class A, Class B, and Class C motor homes along with travel trailers and fifth-wheel towables across about 35 brands. Through the acquisition of Erwin Hymer in 2019, the company expanded its geographic footprint and now produces various motorized and towable recreational vehicles for Europe, including motor caravans, camper vans, urban vehicles, caravans, and other RV-related products and services. The company has also begun generating revenue through aftermarket component parts via the acquisition of Airxcel in 2021; however, this is still a nascent part of the business, as it accounted for less than 10% of fiscal 2025 total sales. In fiscal 2025, the company wholesaled 181,388 units and generated $9.6 billion in revenue.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Share on Social Networks: